Diagnosis and Non-Surgical Management of Urinary Incontinence – A Literature Review with Recommendations for Practice

References

• Irwin DE, Milson I, Hunskaar S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol. 2006;50(6):1306–1314. doi:10.1016/j.eururo.2006.09.019
   PubMed Web of Science ®Google Scholar
• Nambiar AK, Bosch R, Cruz F, et al. EAU guidelines on assessment and nonsurgical management of urinary incontinence. Eur Urol. 2018;73(4):596–609. doi:10.1016/j.eururo.2017.12.031
   PubMed Web of Science ®Google Scholar
• Abrams P, Cardozo L, Wagg A, Wein A, editors. 6th international consultation on incontinence. Tokyo; 2016.
   Google Scholar
• Kobashi KC, Albo ME, Dmochowski RR, et al. Surgical treatment of female urinary incontinence: AUA/SUFU guideline. J Urol. 2017;198:875. doi:10.1016/j.juro.2017.06.061
   PubMed Web of Science ®Google Scholar
• Lightner DJ, Gomelsky A, Souter L, et al. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline. J Urol. 2019;202:558. doi:10.1097/JU.0000000000000309
   PubMed Web of Science ®Google Scholar
• Gormley EA, Lightner DJ, Burgio KL, et al. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline. J Urol. 2012;188:2455. doi:10.1016/j.juro.2012.09.079
   PubMed Web of Science ®Google Scholar
• NICE guidelines: urinary incontinence and pelvic organ prolapse in women (NG123); April 2019.
   Google Scholar
• Fenner DE, Trowbridge ER, Patel DA, et al. Establishing the prevalence of incontinence study: racial differences in women’s patterns of urinary incontinence. J Urol. 2018;179(4):1455–1460. doi:10.1016/j.juro.2007.11.051
   Web of Science ®Google Scholar
• Bradley CS, Erickson BA, Messersmith EE, et al. Evidence of the impact of diet, fluid intake, caffeine, alcohol and tobacco on lower urinary tract symptoms: a systematic review. J Urol. 2017;198(5):1010–1020. doi:10.1016/j.juro.2017.04.097
   PubMed Web of Science ®Google Scholar
• Subak LL, Richter HE, Hunskaar S. Obesity and urinary incontinence: epidemiology and clinical research update. J Urol. 2009;182(6 Suppl):S2–S7. doi:10.1016/j.juro.2009.08.071
   PubMed Web of Science ®Google Scholar
• Kawahara T, Ito H, Yao M, Uemura H. Impact of smoking habit on overactive bladder symptoms and incontinence in women. Int J Urol. 2020;27(12):1078–1086. doi:10.1111/iju.14357
   PubMed Web of Science ®Google Scholar
• Drake MJ, Nixon PM, Crew JP. Drug-induced bladder and urinary disorders. Incidence, prevention and management. Drug Saf. 1998;19(1):45–55. doi:10.2165/00002018-199819010-00004
   PubMed Web of Science ®Google Scholar
• Abrams P, Avery K, Gardener N, Donovan J; ICIQ Advisory Board. The international consultation on incontinence modular questionnaire. J Urol. 2006;175(3 Pt 1):1063–1066. doi:10.1016/S0022-5347(05)00348-4
   PubMed Web of Science ®Google Scholar
• Ouslander JG, Schapira M, Schnelle JF, et al. Does eradicating bacteriuria affect the severity of chronic urinary incontinence in nursing home residents? Ann Intern Med. 1995;122:749–754. doi:10.7326/0003-4819-122-10-199505150-00003
   PubMed Web of Science ®Google Scholar
• Drake MJ, Doumouchtsis SK, Hashim H, Gammie A. Fundamentals of urodynamic practice, based on international continence society good urodynamic practices recommendations. Neurourol Urodyn. 2018;37(S6):S50–S60. doi:10.1002/nau.23773
   PubMed Web of Science ®Google Scholar
• Alling Moller L, Lose G, Jorgensen T. Risk factors for lower urinary tract symptoms in women 40 to 60 years of age. Obstet Gynecol. 2000;96(3):446–451. doi:10.1016/S0029-7844(00)00915-7
   PubMed Web of Science ®Google Scholar
• Byles J, Millar CJ, Sibbritt DW, et al. Living with urinary incontinence: a longitudinal study of older women. Age Ageing. 2009;38(3):333–338. doi:10.1093/ageing/afp013
   PubMed Web of Science ®Google Scholar
• Kaplan SA, Dmochowski R, Cash BD, et al. Systematic review of the relationship between bladder and bowel function: implications for patient management. Int J Clin Pract. 2013;67(3):205–216. doi:10.1111/ijcp.12028
   PubMed Web of Science ®Google Scholar
• Schnelle JF, Leung FW, Rao SSC, et al. A controlled trial of an intervention to improve urinary and fecal incontinence and constipation. J Am Geriatr Soc. 2010;58(8):1504–1511. doi:10.1111/j.1532-5415.2010.02978.x
   PubMed Web of Science ®Google Scholar
• Brazzelli M, Shirran E, Vale L, et al. Absorbent products for containing urinary and/or fecal incontinence in adults. J Wound Ostomy Continence Nurs. 2002;29(1):45–54.
   PubMedGoogle Scholar
• Chartier-Kastler E, Ballanger P, Petit J, et al. Randomized, crossover study evaluating patient preference and the impact on quality of life of urisheaths vs absorbent products in incontinent men. BJU Int. 2011;108(2):241–247. doi:10.1111/j.1464-410X.2010.09736.x
   PubMed Web of Science ®Google Scholar
• McMurdo ME, Davey PG, Elder MA, et al. A cost-effectiveness study of the management of intractable urinary incontinence by urinary catheterisation or incontinence pads. J Epidemiol Community Health. 1992;46(3):222–226. doi:10.1136/jech.46.3.222
   PubMed Web of Science ®Google Scholar
• Saint S, Kaufman SR, Rogers MAM, et al. Condom versus indwelling urinary catheters: a randomized trial. J Am Geriatr Soc. 2006;54(7):1055–1061. doi:10.1111/j.1532-5415.2006.00785.x
   PubMed Web of Science ®Google Scholar
• Jahn P, Beutner K, Langer G, et al. Types of indwelling urinary catheters for long-term bladder drainage in adults. Cochrane Database Syst Rev. 2012;10:CD004997.
   PubMed Web of Science ®Google Scholar
• Hunter KF, Bharmal A, Moore KN, et al. Long-term bladder drainage: suprapubic catheter versus other methods: a scoping review. Neurourol Urodyn. 2013;32(7):944–951. doi:10.1002/nau.22356
   PubMed Web of Science ®Google Scholar
• Niel-Weise BS, van den Broek PJ, da Silva EM, et al. Urinary catheter policies for long-term bladder drainage. Cochrane Database Syst Rev. 2012;8:CD004201.
   Google Scholar
• Fisher H, Oluboyede Y, Chadwick T, et al. Continuous low-dose antibiotic prophylaxis for adults with repeated urinary tract infections (AnTIC): a randomised, open-label trial. Lancet Infect Dis. 2018;18(9):957–968. doi:10.1016/S1473-3099(18)30279-2
   PubMed Web of Science ®Google Scholar
• Moore KN, Schieman S, Ackerman T, et al. Assessing comfort, safety, and patient satisfaction with three commonly used penile compression devices. Urology. 2004;63(1):150–154. doi:10.1016/j.urology.2003.08.034
   PubMed Web of Science ®Google Scholar
• Lipp A, Shaw C, Glavind K, et al. Mechanical devices for urinary incontinence in women. Cochrane Database Syst Rev. 2014;12:CD001756.
   Google Scholar
• Le Berre M, Presse N, Morin M, et al. What do we really know about the role of caffeine on urinary tract symptoms? A scoping review on caffeine consumption and lower urinary tract symptoms in adults. Neurourol Urodyn. 2020;39(5):1217–1233. doi:10.1002/nau.24344
   PubMed Web of Science ®Google Scholar
• Swithinbank L, Hashim H, Abrams P, et al. The effect of fluid intake on urinary symptoms in women. J Urol. 2005;174(1):187–189. doi:10.1097/01.ju.0000162020.10447.31
   PubMed Web of Science ®Google Scholar
• Dowd TT, Campbell JM, Jones JA, et al. Fluid intake and urinary incontinence in older community-dwelling women. J Community Health Nurs. 1996;13(3):179–186. doi:10.1207/s15327655jchn1303_5
   PubMedGoogle Scholar
• Hashim H, Abrams P. How should patients with an overactive bladder manipulate their fluid intake? BJU Int. 2008;102(1):62–66. doi:10.1111/j.1464-410X.2008.07463.x
   PubMed Web of Science ®Google Scholar
• Hunskaar S. A systematic review of overweight and obesity as risk factors and targets for clinical intervention for urinary incontinence in women. Neurourol Urodyn. 2008;27(8):749–757. doi:10.1002/nau.20635
   PubMed Web of Science ®Google Scholar
• Subak LL, Wing R, West DS, et al. Weight loss to treat urinary incontinence in overweight and obese women. N Engl J Med. 2009;360(5):481–490. doi:10.1056/NEJMoa0806375
   PubMed Web of Science ®Google Scholar
• Knepfler T, Valero E, Triki E, et al. Bariatric surgery improves female pelvic floor disorders. J Visc Surg. 2016;153(2):95–99. doi:10.1016/j.jviscsurg.2015.11.011
   PubMed Web of Science ®Google Scholar
• Subak LL, King WC, Belle SH, et al. Urinary incontinence before and after bariatric surgery. JAMA Intern Med. 2015;175(8):1378–1387. doi:10.1001/jamainternmed.2015.2609
   PubMed Web of Science ®Google Scholar
• Eliasson K, Nordlander I, Larson B, et al. Influence of physical activity on urinary leakage in primiparous women. Scand J Med Sci Sports. 2005;15(2):87–94. doi:10.1111/j.1600-0838.2004.407.x
   PubMed Web of Science ®Google Scholar
• Kikuchi A, Niu K, Ikeda Y, et al. Association between physical activity and urinary incontinence in a community-based elderly population aged 70 years and over. Eur Urol. 2007;52(3):868–874. doi:10.1016/j.eururo.2007.03.041
   PubMed Web of Science ®Google Scholar
• Hannestad YS, Rortveit G, Daltveit AK, et al. Are smoking and other lifestyle factors associated with female urinary incontinence? The Norwegian EPINCONT study. BJOG. 2003;110(3):247–254. doi:10.1046/j.1471-0528.2003.02327.x
   PubMed Web of Science ®Google Scholar
• Nygaard I, DeLancey JO, Arnsdorf LI, et al. Exercise and incontinence. Obstet Gynecol. 1990;75(5):848–851.
   PubMed Web of Science ®Google Scholar
• Brown WJ, Miller YD. Too wet to exercise? Leaking urine as a barrier to physical activity in women. J Sci Med Sport. 2001;4(4):373–378. doi:10.1016/S1440-2440(01)80046-3
   PubMed Web of Science ®Google Scholar
• Kim H, Suzuki T, Yoshida Y, et al. Effectiveness of multidimensional exercises for the treatment of stress urinary incontinence in elderly community-dwelling Japanese women: a randomized, controlled, crossover trial. J Am Geriatr Soc. 2007;55(12):1932–1939. doi:10.1111/j.1532-5415.2007.01447.x
   PubMed Web of Science ®Google Scholar
• Kim H, Yoshida H, Suzuki T, et al. The effects of multidimensional exercise treatment on community-dwelling elderly Japanese women with stress, urge, and mixed urinary incontinence: a randomized controlled trial. Int J Nurs Stud. 2011;48(10):1165–1172. doi:10.1016/j.ijnurstu.2011.02.016
   PubMed Web of Science ®Google Scholar
• Bump RC, McClish DK. Cigarette smoking and urinary incontinence in women. Am J Obstet Gynecol. 1992;167(5):1213–1218. doi:10.1016/S0002-9378(11)91691-3
   PubMed Web of Science ®Google Scholar
• Imamura M, Abrams P, Bain C, et al. Systematic review and economic modelling of the effectiveness and cost-effectiveness of non-surgical treatments for women with stress urinary incontinence. Health Technol Assess. 2010;14(40):1–188. doi:10.3310/hta14400
   PubMed Web of Science ®Google Scholar
• Available from: https://www.ics.org/glossary/conservativemanagmentfemale/behaviouralandcognitivetherapies. Accessed August 3, 2021.
   Google Scholar
• Bo K, Frawley HC, Haylen BT, et al. An international urogynecological association (IUGA) /international continence society (ICS) joint report on the terminology for the conservative management of pelvic floor dysfunction (in committee review). Int Urogynecol J. 2017;28:191. doi:10.1007/s00192-016-3123-4
   PubMed Web of Science ®Google Scholar
• Wallace SA, Roe B, Williams K, Palmer M. Bladder training for urinary incontinence in adults. Cochrane Database Syst Rev. 2004;1. doi:10.1002/14651858.CD001308.pub2
   Google Scholar
• Burkhard FC, Bosch JLHR, Cruz F, Lemack GE, Nambiar AK, Thiruchelvam N. EAU guidelines on urinary incontinence in adults; 2018.
   Google Scholar
• Newman D, Butcher HK. Evidence-based practice guideline. prompted voiding for individuals with urinary incontinence. J Gerontol Nurs. 2019;45(2):14–26. doi:10.3928/00989134-20190111-03
   PubMed Web of Science ®Google Scholar
• Dumoulin C, Cacciari LP, Hay-Smith EJC. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database Syst Rev. 2018;10. doi:10.1002/14651858.CD005654.pub4
   PubMed Web of Science ®Google Scholar
• Sherburn M, Bird M, Carey M, et al. Incontinence improves in older women after intensive pelvic floor muscle training: an assessor-blinded randomized controlled trial. Neurourol Urodyn. 2011;30(3):317. doi:10.1002/nau.20968
   PubMed Web of Science ®Google Scholar
• Berghmans B, van Waalwijk van Doorn E, Nieman F, et al. Efficacy of physical therapeutic modalities in women with proven bladder overactivity. Eur Urol. 2002;41:581. doi:10.1016/S0302-2838(02)00178-1
   PubMed Web of Science ®Google Scholar
• Anderson CA, Omar MI, Campbell SE, Hunter KF, Cody JD, Glazener CMA. Conservative management for postprostatectomy urinary incontinence. Cochrane Database Syst Rev. 2015;1. doi:10.1002/14651858.CD001843.pub5
   PubMed Web of Science ®Google Scholar
• Wang, Wang W, Huang QM, et al. Effectiveness of preoperative pelvic floor muscle training for urinary incontinence after radical prostatectomy: a meta-analysis. BMC Urol. 2014;14(1):99.
   PubMed Web of Science ®Google Scholar
• Stewart F, Gameiro LF, El Dib R, Gameiro MO, Kapoor A, Amaro JL. Electrical stimulation with non-implanted electrodes for overactive bladder in adults. Cochrane Database Syst Rev. 2016;12. doi:10.1002/14651858.CD010098.pub4
   PubMed Web of Science ®Google Scholar
• Alka AB, Tailor V, Fernando R, et al. Posterior tibial nerve stimulation for overactive bladder—techniques and efficacy. Int Urogynecol J. 2020;31:865–870. doi:10.1007/s00192-019-04186-3
   PubMed Web of Science ®Google Scholar
• de Wall L, Heesakkers J. Effectiveness of percutaneous tibial nerve stimulation in the treatment of overactive bladder syndrome. Re Rep Urol. 2017;9:145–157. doi:10.2147/RRU.S124981
   PubMed Web of Science ®Google Scholar
• Sun-Ho P, Han S-R, Kwon O-J, et al. Acupuncture for the treatment of urinary incontinence: a review of randomized controlled trials. Exp Ther Med. 2013;6(3):773–780. doi:10.3892/etm.2013.1210
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhishun L, Peng W, Zhao J, Liu B. Acupuncture for stress urinary incontinence in adults. Cochrane Database Syst Rev. 2013;7. doi:10.1002/14651858.CD009408.pub2
   Web of Science ®Google Scholar
• Liu Z, Liu Y, Xu H, et al. Effect of electroacupuncture on urinary leakage among women with stress urinary incontinence: a randomized clinical trial. JAMA. 2017;317:2493–2501. doi:10.1001/jama.2017.7220
   PubMed Web of Science ®Google Scholar
• Zhao Y, Zhou J, Mo Q, et al. Acupuncture for adults with overactive bladder: a systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore). 2018;97(8):e9838. doi:10.1097/MD.0000000000009838
   PubMed Web of Science ®Google Scholar
• Iosif CS, Batra S, Ek A, Astedt B. Estrogen receptors in the human female lower urinary tract. Am J Obstet Gynecol. 1981;141(7):817–820. doi:10.1016/0002-9378(81)90710-9
   PubMed Web of Science ®Google Scholar
• Rud T, Andersson KE, Asmussen M, Hunting A, Ulmsten U. Factors maintaining the intraurethral pressure in women. Invest Urol. 1980;17(4):343–347.
   PubMedGoogle Scholar
• Cody JD, Jacobs ML, Richardson K, Moehrer B, Hextall A. Oestrogen therapy for urinary incontinence in post-menopausal women. Cochrane Database Syst Rev. 2012;10(10):CD001405.
   PubMedGoogle Scholar
• Andersson KE, Chapple C, Wein A. The basis for drug treatment of the overactive bladder. World J Urol. 2001;19(5):294–298. doi:10.1007/PL00007101
   PubMed Web of Science ®Google Scholar
• Andersson KE. Antimuscarinics for treatment of overactive bladder. Lancet Neurol. 2004;3(1):46–53. doi:10.1016/S1474-4422(03)00622-7
   PubMed Web of Science ®Google Scholar
• Harvey MA, Baker K, Wells GA. Tolterodine versus oxybutynin in the treatment of urge urinary incontinence: a meta-analysis. Am J Obstet Gynecol. 2001;185(1):56–61. doi:10.1067/mob.2001.116371
   PubMed Web of Science ®Google Scholar
• Nabi G, Cody JD, Ellis G, Herbison P, Hay-Smith J. Anticholinergic drugs versus placebo for overactive bladder syndrome in adults. Cochrane Database Syst Rev. 2006;18(4):CD003781.
   Google Scholar
• Ouslander JG. Management of overactive bladder. N Engl J Med. 2004;350(8):786–799. doi:10.1056/NEJMra032662
   PubMed Web of Science ®Google Scholar
• Ellsworth P, Kirshenbaum E. Update on the pharmacologic management of overactive bladder: the present and the future. Urol Nurs. 2010;30(1):29–38, 53. doi:10.7257/1053-816X.2010.30.1.29
   PubMedGoogle Scholar
• Gray SL, Anderson ML, Dublin S, et al. Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study. JAMA Intern Med. 2015;175(3):401–407. doi:10.1001/jamainternmed.2014.7663
   PubMed Web of Science ®Google Scholar
• D’Souza AO, Smith MJ, Miller LA, Doyle J, Ariely R. Persistence, adherence, and switch rates among extended-release and immediate-release overactive bladder medications in a regional managed care plan. J Manag Care Pharm. 2008;14(3):291–301. doi:10.18553/jmcp.2008.14.3.291
   PubMed Web of Science ®Google Scholar
• Benner JS, Nichol MB, Rovner ES, et al. Patient-reported reasons for discontinuing overactive bladder medication. BJU Int. 2010;105(9):1276–1282. doi:10.1111/j.1464-410X.2009.09036.x
   PubMed Web of Science ®Google Scholar
• Yu YF, Nichol MB, Yu AP, Ahn J. Persistence and adherence of medications for chronic overactive bladder/urinary incontinence in the California Medicaid program. Value Health. 2005;8(4):495–505. doi:10.1111/j.1524-4733.2005.00041.x
   PubMed Web of Science ®Google Scholar
• Igawa Y, Yamazaki Y, Takeda H, et al. Possible beta 3-adrenoceptor-mediated relaxation of the human detrusor. Acta Physiol Scand. 1998;164(1):117–118. doi:10.1046/j.1365-201X.1998.00406.x
   PubMedGoogle Scholar
• Tyagi P, Tyag V. Mirabegron, a β3-adrenoceptor agonist for the potential treatment of urinary frequency, urinary incontinence or urgency associated with overactive bladder. IDrugs. 2010;13(10):713–722.
   PubMed Web of Science ®Google Scholar
• Sacco E, Bientinesi R. Mirabegron: a review of recent data and its prospects in the management of overactive bladder. Ther Adv Urol. 2012;4(6):315–324. doi:10.1177/1756287212457114
   PubMedGoogle Scholar
• Cui Y, Zong H, Yang C, Yan H, Zhang Y. The efficacy and safety of mirabegron in treating OAB: a systematic review and meta-analysis of Phase III trials. Int Urol Nephrol. 2014;46(1):275–284. doi:10.1007/s11255-013-0509-9
   PubMed Web of Science ®Google Scholar
• Nitti VW, Rosenbery S, Mitcheson DH, et al. Urodynamics and safety of the β3-adrenoceptor agonist mirabegron in males with lower urinary tract symptoms and bladder outlet obstruction. J Urol. 2013;190(4):1320–1327. doi:10.1016/j.juro.2013.05.062
   PubMed Web of Science ®Google Scholar
• Caremel R, Loutochin O, Corcos J. What do we know and not know about mirabegron, a novel β3 agonist, in the treatment of overactive bladder? Int Urogynecol J. 2014;25(2):165–170. doi:10.1007/s00192-013-2161-4
   PubMed Web of Science ®Google Scholar
• Wagg A, Cardozo L, Nitti VW, et al. The efficacy and tolerability of the beta3-adrenoceptor agonist mirabegron for the treatment of symptoms of overactive bladder in older patients. Age Ageing. 2014;43(5):666–675. doi:10.1093/ageing/afu017
   PubMed Web of Science ®Google Scholar
• MacDiarmid S, Al-Shukri S, Barkin J, et al. Mirabegron as add-on treatment to solifenacin in patients with incontinent overactive bladder and an inadequate response to solifenacin monotherapy. J Urol. 2016;196:809–818. doi:10.1016/j.juro.2016.03.174
   PubMed Web of Science ®Google Scholar
• Thor KB, Katofiasc MA. Effects of duloxetine, a combined serotonin and norepinephrine reuptake inhibitor, on central neural control of lower urinary tract function in the chloralose-anesthetized female cat. J Pharmacol Exp Ther. 1995;274(2):1014–1024.
   PubMed Web of Science ®Google Scholar
• Athanasiou S, Chaliha C, Digesu GA, et al. The effects of duloxetine on urethral function and sphincter morphology. Int Urogynecol J Pelvic Floor Dysfunct. 2007;18(7):763–767. doi:10.1007/s00192-006-0230-7
   PubMed Web of Science ®Google Scholar
• Chung E. Desmopressin and nocturnal voiding dysfunction: clinical evidence and safety profile in the treatment of nocturia. Expert Opin Pharmacother. 2018;19(3):291–298. doi:10.1080/14656566.2018.1429406
   PubMed Web of Science ®Google Scholar
• Weiss JP, Zinner NR, Klein BM, Nørgaard JP. Desmopressin orally disintegrating tablet effectively reduces nocturia: results of a randomized, double-blind, placebo-controlled trial. Neurourol Urodyn. 2012;31(4):441–447. doi:10.1002/nau.22243
   PubMed Web of Science ®Google Scholar
• Mattiasson A, Abrams P, Van Kerrebroeck P, Walter S, Weiss J. Efficacy of desmopressin in the treatment of nocturia: a double-blind placebo-controlled study in men. BJU Int. 2002;89(9):855–862. doi:10.1046/j.1464-410X.2002.02791.x
   PubMed Web of Science ®Google Scholar